Study of Efficacy of CDZ173 in Patients With APDS/PASLI
Clinical trial NCT02435173 · COMPLETED
Trial details
- NCT number
- NCT02435173
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-24
- Primary completion
- 2021-08-16
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.